MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00266-026-05946-5

Медицинская библиотека · Aesthetic plastic surgery · 2026

The Efficacy and Safety of Platelet-Rich Plasma in the Treatment of Melasma: A Systematic Review and Meta-analysis.

Ma Chen, Wang Qixuan, Zhang Ling

СтатьяСистематический обзорМетаанализПеревод в очереди

Аннотация

BACKGROUND

Platelet-rich plasma (PRP) therapy has emerged as a potential treatment for melasma, though its efficacy remains incompletely evaluated. This systematic review and meta-analysis assessed the clinical efficacy, patient satisfaction, and safety of PRP for melasma compared to alternative treatments.

METHODS

Following PRISMA guidelines, we conducted a systematic review and meta-analysis of 11 clinical studies. Outcomes included clinical improvement (melasma severity scores), patient satisfaction, and adverse events, analyzed using standardized mean differences (SMD) with 95% confidence intervals (CI). Risk of bias was evaluated using Cochrane RoB 2.0 and ROBINS-I tools.

RESULTS

PRP therapy showed no significant difference in improving the severity of melasma compared to the control therapy. Subgroup analysis indicated that the efficacy of PRP when combined with other therapies was also not significantly different. In terms of treatment duration, significant differences in treatment effects were observed as time increased. In terms of patient satisfaction and adverse events, there were no significant differences between PRP and other treatments. Sensitivity analysis revealed that the overall pooled estimate was sensitive to a single small-scale study, indicating limited statistical robustness of the current results.

CONCLUSION

While PRP shows clinical potential in melasma management, this meta-analysis indicates no significant overall advantage over alternative therapies. Given the limited statistical robustness and high clinical heterogeneity observed, these findings should be interpreted with caution. Future large-scale, standardized, and multi-center clinical trials are essential to provide more definitive evidence regarding its efficacy, safety, and long-term clinical practicability.

LEVEL OF EVIDENCE I: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Для цитирования: Ma Chen, Wang Qixuan, Zhang Ling. The Efficacy and Safety of Platelet-Rich Plasma in the Treatment of Melasma: A Systematic Review and Meta-analysis.. Aesthetic plastic surgery. 2026. DOI: 10.1007/s00266-026-05946-5.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.